InsulIn-lIke growth factor-1 (IGF-1), primarily produced in the liver under the control of growth hormone (GH) [1][2][3][4], mediates most of the major activities of GH [1,2]. Because blood IGF-1 reveals overall GH secretion during the period of prior 24 hrs and minimally fluctuates over this period [5][6][7], its concentration has been a reliable indicator of GH secretion [1,3,8]. Thus, the recent criteria for surgical cure of acromegaly mandate normalization of IGF-1. In the previous report, we showed that the decrease in IGF-1 was slower in operated acromegalic patients than would be expected from the half-life of the carrier protein-bound peptide [9]. And we suggested that this slow decline allows us to postpone decisions regarding the patients' postoperative status and the administration abstract. To know the longitudinal shift of blood IGF-1 of cured acromegaly, we conducted retrospective survey of changes in blood IGF-1 over two years, which has not been previously investigated. Blood IGF-1 levels were measured for longer than 2 years after TSS in 37 patients whose nadir GH during postoperative oral glucose tolerance test (OGTt) was under 1 ng/mL. Blood IGF-1 very gradually declined after three months; 230.6 (mean) ng/mL at 3-12 months, 202.3 ng/mL at 12-24 months, and 198.6 ng/mL at 24-36 months. Their SD values, calculated based on standard IGF-1 values of age-and sex-matched Japanese population, also slowly decreased after three months; 1.69 (mean) at 3-12 months, 1.23 at 12-24 months, and 1.12 at 24-36 months. Very slow decrease of the IGF-1 levels continued beyond the first several months and even the first year after TSS. The declination of values is greater than that associated with aging. This declination may be at least partially a reflection of the slow decrease and late normalization of GH secretion.Key words: Acromegaly, Insulin-like growth factor-1 (IGF-1), Growth hormone, Declination, Transsphenoidal surgery of additional therapy for at least one month after surgery. Since then, we have been monitoring the IGF-1 fluctuations in postoperative acromegalic patients and have observed that IGF-1 very gradually decreased over a year in some patients. In order to know the longitudinal shift of the IGF-1, if any, we retrospectively assessed the blood IGF-1 levels serially for more than two years in postoperative acromegalics.
Materials and Methods
Subjects and methodPatients were 37, 12 males and 25 females, acromegalics who underwent transsphenoidal surgery since 2001 to 2008, whose nadir GH during postoperative OGTt was under 1 ng/mL, and in whom IGF-1 levels were serially measured over two years. The patients' ages ranged from 20 to 76 years (53.5±11.7, mean±SD). The mean preoperative IGF-1 level was 895.0 ± 360.1 (SD) ng/mL. The IGF-1 levels were measured during 1-4 weeks, 1-3 months, 3-12 months, 12-24 months,